A critical advance in cancer research is occurring with the use of mini-antibodies to restore dysfunctional p53. This vital tumor inhibitor protein is frequently disabled in various kinds of tumors, leading https://bookmarkstime.com/story22681684/vhh-fragments-revive-the-p53-protein-the-promising-hope-for-malignant-treatment